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modules for self-selected modules can reduce the total number
of modules required for recertification in internal medicine and
nephrology to six Self-Evaluation Process modules (three in
general internal medicine, three in nephrology) and four Final
Examination modules (two in general internal medicine, two in
nephrology). The score for each recertification Final Examina-
tion will be determined independently. Thus, an individual can
be successful in becoming recertified in nephrology but not in
internal medicine, even when the processes are undertaken
concurrently.
Schedule of availability
This comprehensive recertification program will become
available in 1995. The Self-Evaluation Process will be available
continuously beginning in 1995. Final Examinations will be
available annually beginning in 1996. Diplomates who would
like to become recertified before this time can take a regularly
scheduled certification examination for recertification credit
(interim voluntary recertification).
With this new recertification process, the ABIM provides an
opportunity for internists to meet their commitment to profes-
sional accountability. Recertification will set standards for
high-quality medical care. Success in recertification will recog-
nize the commitment of diplomates to the lifelong scholarship
required for excellence in the care of patients. In developing a
modular design that can be tailored to individual practice and
that stresses self-assessment to promote scholarship, the Board
expects all well-prepared diplomates to be successful in recer-
tification.
AWARDS AND GRANTS
International Fellowship Training Awards
The International Society of Nephrology announces the
establishment of an International Fellowship Training Program
to provide training in clinical nephrology to physicians from
developing countries. It is the objective of this program to
support the growth of nephrology in developing countries
through an educational program that admits qualified applicants
to clinical training in recognized nephrology programs around
the world, and then to return to their home country to practice
and/or teach. In unique circumstances, applicants who wish
basic research training may be considered if the environment in
the home country will permit continued research upon the
completion of training.
The guidelines for application are as follows:
(1) Fellowship awards will be made only to physicians from
developing countries.
(2) Applicants must provide evidence of acceptance into a
recognized and suitable training program before the
award can be granted.
(3) The Fellow must return to his or her home country upon
completion of approved training.
(4) The Fellow must provide evidence of a guaranteed
position in a medical institution upon return to the home
country.
(5) Fellows will receive a stipend from the Society such
that, taking into account the home country and/or the
host institution support that they may have, they
achieve a $20,000 US revenue.
(6) Fellows must be able to read and speak the language of
the host country. An interview may be required to
assess verbal fluency.
(7) Fellowships will be offered primarily for clinical training
of one to two years duration.
(8) Clinical training programs should be practical in their
orientation, and applicable to the needs and conditions
of the home country. The ability of the host institution to
provide such training will be an important factor in the
selection process.
(9) Fellows must have received sufficient training in internal
medicine or other fields to pass all host country exami-
nations that are necessary to the care of patients.
Fellowships may be awarded to senior individuals who
seek additional training but, in general, preference will
be given to younger physicians who are at the beginning
of their permanent careers.
(10) Specific instructions and the necessary application
forms can be obtained by writing directly to Dr. Claude
Arnie!, Secretary General, International Society of
Nephrology, Département de Physiologie, Faculté de
Médecine Xavier Bichat, 16, rue Henri Huchard, 75018-
Paris, France.
1991 ISN's International Fellowship Training Awards
Aza J. J. Abdulla from Medical City Teaching Hospital, Bagh-
dad, Iraq to go to The Royal Free Hospital, London, UK with
John F. Moorhead, M.D.
Maria del Carmen Avila Casado from Instituto Nacional de
Cardiologia, Mexico to go to Brigham and Women's Hospital,
Boston, MA, USA with Helmut G. Rennke, M.D.
Gabriela Garcia Espinosa from Instituto Mexicano del Seguro
Social, Mexico to go to University of California, San Diego,
CA, USA with Roland C. Blantz, M.D.
Tomasz Kozlowski from Institue of Surgery, Central Univer-
sity Hospital, Banacha la, Warsaw, Poland to go to Karolin-
ska Institute, Stockholm, Sweden with C.G. Groth, M.D.
Xiaomei Li from The First Hospital, Beijing Medical Univer-
sity, Beijing, PRC to go to Unviersity of Colorado, School of
Medicine, Denver, CO, USA with Robert W. Schrier, M.D.
Dragan Ljutic from Clinical Hospital "Firule", Split,
Yugoslavia to go to Guy's and St Thomas's Hospitals,
London, UK with J. Stewart Cameron, M.D.
Martin John Luta from Kenyatta National Hospital, Nairobi,
Kenya to go to Guy's Hospital, London, UK with George B.
Haycock, M.D.8
Rafael Villar Ramon from Instituto Nacional de Cardiologia
"Ignacio Chavez", Mexico to go to University of Miami,
Miami, CA, USA with Jacques J. Bourgoignie, M.D.
Maged Tawfic Tadros from The Cairo Kidney Center, Cairo,
Egypt to go to Ente Ospedaliero San Carlo Borromeo,
Milano, Italy with Giuseppe D'Amico, M.D.
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Zhong-fa Yuan from First Affiliated Hospital, Guangshou, PRC
to go to Canterbury Area Health Board, Christchurch Hos-
pital, New Zealand, with Ross R. Bailey, M.D.
Honorary
Yu Lei from Affiliated Hosp. of Guiyang Med. Coll., Guizhou,
PRC to go to Ente Osp. San Carlo Borromeo, Milano, Italy
with Giuseppe D'Amico, M.D.
Erratum
In our recent article [11 reference #24 to Mckenzie et al [21,
the positive immunoperoxidase staining was in the proximal
tubule cells and collecting tubules and ducts of the rat kidney,
while the distal tubules were negative for atrial natriuretic
factor (ANF)-IV (a shortened form of the ANF, consisting of 25
amino acids). The localization of ANF in the study by FiguerOa
et al [31, which was reference #23 of our article [11 localized the
most intense ANF staining to the distal convoluted tubule cells
and collecting tubules and ducts of the human nephron while
'staining was evident in a very few proximal tubules, where it
was found only occasionally in some cells". Thus, in referring
to reference #24 it should have been ANF staining in the
proximal rather than the distal tubules as was stated [1] and in
reference #23 there was some ANF staining in the proximal
tubules as well as the distal tubules. In both these important
studies [2, 3j ANF staining was also present in the collecting
ducts as well. In our immunoperoxidase and immunofluores-
cent investigation of the N-terminal ANF prohormone peptides
[1] where ANF (the C-terminus of the ANF prohormone) was
utilized as a control we were able to confirm that ANF
immunoperoxidase staining occurs in both the proximal and
distal tubules and in the collecting ducts with most intense
staining being in the pars convoluta of the proximal tubules. We
apologize to authors of these two important studies for any
confusion with respect to the discussion of ANF immunoper-
oxidase staining in these two articles as we did not intend to
misrepresent any of the findings of their investigations.
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Erratum
In the manuscript "Multiple patterns of 1 1/3-hydroxysteroid
dehydrogenase catalytic activity along the mammalian neph-
ron." by Sabine Kenouch, Nathalie Coutry, Nicolette Farman,
and Jean-Pierre Bonvalet, Kidney International, 42:56—60,
1992, there is an error in units in the text and Figs. 2 and 3: all
values of metabolism are in l0_16 moles per sample, and not in
picomoles per sample.
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